FDA identifies eight deaths tied to Amgen's Tavneos

Max Bayer / endpoints - The FDA on Tuesday flagged more than 70 cases of severe liver injury and eight deaths associated with Amgen’s autoimmune treatment Tavneos, but the company said it previously notified the agency about the risk of ...

AI Summary: The FDA has tied eight patient deaths to Amgen’s drug Tavneos, prompting heightened regulatory review and industry concern. Reports outline safety signals and agency actions as clinicians and manufacturers reassess risk‑benefit profiles, while regulators weigh labeling, monitoring or other interventions to protect patients.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

FDA launches individualized therapy framework for ultra-rare diseases / 3 months

FDA makes one pivotal trial the default for drug approvals / 3 months

FDA refuses to review Moderna mRNA flu vaccine application / 3 months

FDA rejects Atara cell therapy for Epstein–Barr virus complications / 4 months

Boehringer gains fast approval for first‑line lung cancer drug via voucher program / 3 months

FDA commissioner Marty Makary resigns amid mounting scrutiny / 19 days

World Cancer Day Global Awareness Campaign / 3 months